We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$56.3B
AUM Growth
+$6.69B
Cap. Flow
+$3.22B
Cap. Flow %
5.72%
Top 10 Hldgs %
48.94%
Holding
2,783
New
180
Increased
516
Reduced
1,266
Closed
728

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$124M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$107M
3
VO icon
Vanguard Mid-Cap ETF
VO
+$91.2M
4
PEP icon
PepsiCo
PEP
+$81M
5
TSLA icon
Tesla
TSLA
+$78.9M

Sector Composition

Rank Sector Weight
1 Technology 4.17%
2 Financials 2.89%
3 Consumer Discretionary 1.75%
4 Communication Services 1.7%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CS
2676
DELISTED
Credit Suisse Group
CS
-14,228
Closed -$151K
BIOC
2677
DELISTED
Biocept, Inc.
BIOC
-393
Closed -$60K
VNTR
2678
DELISTED
Venator Materials PLC
VNTR
-85,200
Closed -$394K
MAXR
2679
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-11,709
Closed -$443K
HZON
2680
DELISTED
Horizon Acquisition Corporation II
HZON
-75,040
Closed -$765K
HZON.WS
2681
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
-100,000
Closed -$205K
ML
2682
DELISTED
MoneyLion Inc.
ML
-487
Closed -$145K
VLTA
2683
DELISTED
Volta Inc.
VLTA
-10,709
Closed -$117K
AUY
2684
CALL
DELISTED
Yamana Gold, Inc.
AUY
-3,500
Closed -$1K
ATCO
2685
DELISTED
Atlas Corp.
ATCO
-19,288
Closed -$263K
SIOX
2686
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-56,728
Closed -$148K
OBSV
2687
DELISTED
ObsEva SA Ordinary Shares
OBSV
-24,960
Closed -$81K
TMDI
2688
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
-69,914
Closed -$119K
CAJ
2689
DELISTED
Canon, Inc.
CAJ
-10,528
Closed -$240K
VLDR
2690
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-14,129
Closed -$161K
SJI
2691
DELISTED
South Jersey Industries, Inc.
SJI
-13,409
Closed -$303K
VIVO
2692
DELISTED
Meridian Bioscience Inc
VIVO
-64,044
Closed -$1.68M
SVFAU
2693
DELISTED
SVF Investment Corp. Unit
SVFAU
-16,309
Closed -$172K
TTM
2694
DELISTED
Tata Motors Limited
TTM
-26,829
Closed -$558K
EPHYU
2695
DELISTED
Epiphany Technology Acquisition Corp. Unit
EPHYU
-10,320
Closed -$104K
HCICU
2696
DELISTED
Hennessy Capital Investment Corp. V Units
HCICU
-28,881
Closed -$292K
COLIU
2697
DELISTED
Colicity Inc. Units
COLIU
-11,040
Closed -$112K
NDACU
2698
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
-11,100
Closed -$113K
ZEN
2699
CALL
DELISTED
ZENDESK INC
ZEN
-2,000
Closed -$111K
HAAC
2700
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
-14,850
Closed -$152K

Similar funds

Creative Planning's Q2 2021 Portfolio in Review

As of Q2 2021, Creative Planning held 2,783 positions worth $56.3B, up 13% from $49.6B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Creative Planning deployed $3.22B of net new capital in Q2 2021, opening 180 new positions and adding to 516 existing holdings. Its largest new stake was Dimensional US Small Cap ETF: 5,736,810 shares worth $335M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 4.9% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $124M trimmed.

  • Creative Planning's largest Q2 2021 buy was Dimensional US Small Cap ETF: 5,736,810 shares worth $335M.
  • Creative Planning added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1B increase.
  • Creative Planning's biggest Q2 2021 reduction was Apple, cutting an estimated $124M.
  • Creative Planning fully exited LCNB Corp in Q2 2021, selling an estimated $9.35M.
  • Creative Planning's ten largest holdings make up 49% of its $56.3B portfolio in Q2 2021.
  • Creative Planning opened 180 new positions and closed 728 in Q2 2021.
  • Creative Planning's portfolio value rose 13% quarter-over-quarter to $56.3B.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.